Cargando…
Diagnosis of Sickle Cell Disease and HBB Haplotyping in the Era of Personalized Medicine: Role of Next Generation Sequencing
Hemoglobin genotype and HBB haplotype are established genetic factors that modify the clinical phenotype in sickle cell disease (SCD). Current methods of establishing these two factors are cumbersome and/or prone to errors. The throughput capability of next generation sequencing (NGS) makes it ideal...
Autores principales: | Adekile, Adekunle, Akbulut-Jeradi, Nagihan, Al Khaldi, Rasha, Fernandez, Maria Jinky, Sukumaran, Jalaja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8224627/ https://www.ncbi.nlm.nih.gov/pubmed/34071035 http://dx.doi.org/10.3390/jpm11060454 |
Ejemplares similares
-
Unique Polymorphisms at BCL11A, HBS1L-MYB and HBB Loci Associated with HbF in Kuwaiti Patients with Sickle Cell Disease
por: Akbulut-Jeradi, Nagihan, et al.
Publicado: (2021) -
A phased SNP-based classification of sickle cell anemia HBB haplotypes
por: Shaikho, Elmutaz M., et al.
Publicado: (2017) -
Presence of atypical beta globin (HBB) gene cluster haplotypes in sickle cell anemia patients of India
por: Nongbri, Sandor Rudy L., et al.
Publicado: (2017) -
Alpha thalassemia genotypes in Kuwait
por: Adekile, Adekunle, et al.
Publicado: (2020) -
What's New in the Pathophysiology of Sickle Cell Disease?
por: Adekile, Adekunle D.
Publicado: (2013)